The pharmacological basis for the treatment of brain ischemia and hypoxia.
Wauquier
A
A
Department of Neuropharmacology, Janssen Pharmaceutica, Beerse, Belgium.
Ashton
D
D
D000241:Adenosine / Q000378:metabolism; D000596:Amino Acids / Q000502:physiology; D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D002560:Cerebrovascular Circulation; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D002534:Hypoxia, Brain / Q000188:drug therapy* / Q000503:physiopathology; D010100:Oxygen / Q000378:metabolism; D014665:Vasodilator Agents / Q000627:therapeutic use
D000596:Amino Acids; D005230:Fatty Acids, Nonesterified; D014665:Vasodilator Agents; D000241:Adenosine; D010100:Oxygen; D002118:Calcium